Speech-Language Therapy for Aphasia
(TERRA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of remotely delivered speech-language therapy compared to traditional in-clinic sessions for people with aphasia, a condition that affects communication skills after a stroke. Participants will engage in both semantically-focused (meaning-based) and phonologically-focused (sound-based) therapy tasks. The trial aims to determine if online therapy can be as beneficial as face-to-face sessions. Ideal candidates are those who experienced a stroke affecting the left side of the brain at least a year ago and primarily speak English. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve access to effective therapy for others with similar conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these therapy methods are safe for aphasia treatment?
Research has shown that both sound-focused and meaning-focused therapy tasks are generally safe for people with aphasia. These therapies are well-known and have been used to improve language skills after a stroke.
Studies have found that phonological components analysis, a part of sound-focused therapy, is a popular method for helping people find words more easily. Strong evidence supports its use, and it has been applied successfully without reports of serious side effects.
Similarly, semantic feature analysis, a meaning-focused therapy, is widely used. It aids people with aphasia by concentrating on the meanings of words. This technique is well-tolerated and has shown positive results in improving language abilities.
Overall, these therapies are considered safe and effective for those seeking to improve their speech and language skills after a stroke. No significant adverse events are commonly associated with these treatments.12345Why are researchers excited about this trial?
Researchers are excited about these speech-language therapy methods for aphasia because they offer a fresh approach to rehabilitation. Unlike traditional in-person therapy sessions, the Aphasia Remote Therapy (ART) allows participants to engage in treatment from home, using an online platform and teletherapy kits, which could make therapy more accessible and convenient. Meanwhile, the In-Clinic Therapy (I-CT) maintains the standard face-to-face interaction, ensuring comprehensive support from a speech-language pathologist. Both treatments uniquely combine semantically and phonologically-focused tasks, potentially enhancing the effectiveness of therapy by targeting different language processing areas. By examining the order and setting of these treatments, researchers hope to uncover optimal strategies for improving communication in people with aphasia.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research has shown that two types of therapy tasks can help people with aphasia improve their ability to find words and communicate. In this trial, participants will receive both types of therapy. One type, Phonological Components Analysis, focuses on the sounds in words. This method helps people find words by breaking them down into individual sounds, and studies have shown it can greatly improve naming skills. The other type, Semantic Feature Analysis, focuses on the meanings of words. This approach helps by having people describe the features of words, and it has been effective in improving naming difficulties. Both therapy methods have shown promise in aiding recovery from aphasia.16789
Who Is on the Research Team?
Julius Fridriksson, Ph.D
Principal Investigator
University of South Carolina
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 21-80 who've had a left hemisphere stroke at least a year ago and can consent to treatment. They must be MRI compatible without metal implants or claustrophobia, and have no history of other brain diseases or severe speech/comprehension impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 weeks of daily semantically-focused treatment and 3 weeks of daily phonologically-focused treatment, either remotely or in-clinic
Follow-up
Participants are monitored for changes in speech production and quality of life after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Phonologically-focused therapy tasks
- Semantically-focused therapy tasks
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Medical University of South Carolina
Collaborator